Research

Energy balance

In severe diabetes, reduced cardiac lipoprotein lipase (LPL) activity forces cardiomyocytes to rely on non-esterified fatty acids (NEFA) from adipose tissue, causing mitochondrial overload, lipid metabolite accumulation, and cardiac lipotoxicity.

In severe diabetes, the heart's ability to process fat from blood lipids (via LPL) drops. This forces the heart to burn fat directly from the blood (NEFA), which it cannot handle efficiently, leading to damage. Treatments must focus on restoring this specific fat-processing pathway in the heart, not just lowering overall blood fat.

ModerateSupportsMEDIUM confidence
This excessive supply of NEFA overwhelmed the mitochondrial capacity, leading to a mismatch between FA delivery and utilization, lipid metabolite build-up and cell death (Figure 2) [30].
Rui Shang et al. · Journal of Pharmacy & Pharmaceutical Sciences · 2024

Why this rating

Based on animal models (STZ-induced diabetes) and in vitro studies; human clinical data is referenced but specific trial outcomes for this specific mechanism are not detailed.

Source

Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease

Rui Shang et al. · Journal of Pharmacy & Pharmaceutical Sciences · 2024

DOI 10.3389/jpps.2024.13199

narrative_reviewCited 18×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →